A free testosterone test measures or estimates the small fraction of testosterone not bound to proteins. It is most useful when total testosterone and symptoms do not agree or when sex hormone-binding globulin (SHBG) is unusually high or low. In men, low free testosterone may support hypogonadism only when compatible symptoms are present and repeat morning testing confirms the pattern. In women, high free testosterone can support biochemical androgen excess, often associated with PCOS, but a rapid change or marked elevation requires evaluation for adrenal or ovarian causes. Direct free-testosterone immunoassays can be inaccurate, especially at the low concentrations found in women. Equilibrium dialysis is a reference method, while validated calculations use total testosterone, SHBG, and albumin. There is no universal normal range because methods and populations differ. Age, sex, time of day, obesity, thyroid or liver disease, medicines, hormone therapy, and assay quality all influence the result.
- Free testosterone is the unbound fraction; it is usually estimated from total testosterone, SHBG, and albumin.
- Testing is most useful when SHBG is abnormal or total testosterone and symptoms conflict.
- Men need symptoms plus repeat low morning results before a diagnosis of testosterone deficiency.
- High free testosterone in women commonly occurs with PCOS but rapid virilization needs urgent evaluation.
- Equilibrium dialysis or a validated calculation is more reliable than many direct analog immunoassays.
- Testosterone treatment can suppress sperm production and should be planned around fertility goals.
Table of Contents
- What the free testosterone Test Measures
- Why the Test Is Ordered
- Preparation, Timing, and the Testing Process
- Normal Range and How Results Are Interpreted
- What High free testosterone Results Can Mean
- What Low free testosterone Results Can Mean
- How Results Fit With Other Hormones and Tests
- Next Steps After the Result
What the free testosterone Test Measures
Approximately 1–3% of circulating testosterone is unbound, although the proportion varies with SHBG and albumin. Free testosterone can enter tissues, but the simple “free hormone” model does not capture every transport and receptor process. Clinically, the measurement is valuable because binding changes can make total testosterone misleading.
High SHBG lowers the free fraction for a given total concentration. Low SHBG raises it. A calculation combines total testosterone, SHBG, and albumin using binding assumptions. Equilibrium dialysis physically separates free hormone and is technically demanding but remains a reference approach.
A hormone result is a measurement made under defined laboratory conditions, not a diagnosis by itself. The same concentration can carry different meaning at different ages, cycle stages, pregnancy stages, or times of day. Laboratories also use different analyzers, calibration systems, antibodies, and calculation methods. For that reason, the reference interval printed beside the result should take priority over a range copied from another report or website.
A direct analog free-testosterone assay is not the same as equilibrium dialysis and may not provide accurate results. The report should identify the method or calculation. Results from different methods should not be trended as though they were interchangeable.
The SHBG test explains common causes of abnormal binding and discordant testosterone results.
Why the Test Is Ordered
Free testosterone is a second-line or clarifying test in many settings rather than the first hormone ordered.
- Symptoms of androgen deficiency with borderline total testosterone in a man.
- Obesity, aging, thyroid disease, liver disease, estrogen exposure, or another cause of abnormal SHBG.
- Clinical androgen excess in a woman with normal or borderline total testosterone.
- Monitoring selected testosterone treatments when total levels are hard to interpret.
- Evaluating pituitary-gonadal patterns with LH, FSH, and prolactin.
- Confirming an unexpected result from a less reliable direct assay.
In men, reduced libido, erectile change, infertility, low bone density, anemia, and loss of muscle are more specific than fatigue alone. In women, acne and hair growth are common and can occur without a major biochemical elevation. Testing should be driven by the clinical pattern, not by nonspecific wellness concerns.
Interpretation starts with the reason the test was ordered. A clinician looking for an adrenal enzyme disorder uses different cutoffs and follow-up tests than a clinician evaluating irregular periods, infertility, menopausal symptoms, or androgen deficiency. The result should be read with symptoms, examination findings, age, reproductive stage, and related laboratory values rather than compared with one universal “optimal” number.
A reliable total testosterone result is needed for most free-testosterone calculations.
Preparation, Timing, and the Testing Process
Men should usually have blood drawn in the morning after their main sleep period and repeat a low result on another day.
- Confirm the method: equilibrium dialysis, ultrafiltration, validated calculation, or direct immunoassay.
- Schedule morning testing in men and document shift-work sleep timing.
- List testosterone, anabolic steroids, estrogens, contraceptives, thyroid medicines, anticonvulsants, opioids, and glucocorticoids.
- Record the time since the last hormone dose, injection, gel application, or patch change.
- Postpone routine diagnosis during acute illness when clinically appropriate.
Women are often tested in the morning and, if cycling, early in the follicular phase for consistency. In people on testosterone treatment, the correct draw time depends on the formulation. A trough for one product and a mid-interval sample for another cannot be compared directly.
Before collection, provide a complete list of prescription medicines, over-the-counter products, supplements, contraceptives, fertility drugs, and hormone therapy. Do not stop prescribed treatment without instructions. Some products change hormone production, while others alter binding proteins or interfere with an immunoassay. High-dose biotin is a well-known source of interference in several hormone tests, although the direction and size of the error depend on the platform.
Acute illness can temporarily suppress or stimulate reproductive signaling. A test drawn during fever, major surgery, severe calorie restriction, or intense training may describe that temporary state rather than the person’s usual hormone function. When the clinical situation is stable and there is no urgent reason to test immediately, postponing or repeating the measurement can prevent an incorrect label.
Normal Range and How Results Are Interpreted
Free testosterone may be reported in pg/mL, ng/dL, pmol/L, or another unit. Adult male and female intervals differ by more than an order of magnitude, and age affects both.
| SHBG state | Total testosterone appearance | Free testosterone effect |
|---|---|---|
| High SHBG | May look normal or high | Free fraction can be low |
| Low SHBG | May look low | Free fraction can be normal or high |
| Normal SHBG | Total often reflects androgen status reasonably | Free testing may add less |
| Changing SHBG on treatment | Trend can be misleading | Recalculate with current SHBG |
| Assay error at low level | Total may be unreliable | Use mass spectrometry and a validated free method |
Do not compare a calculated value with an equilibrium-dialysis interval unless the laboratory specifically validates that comparison. In men, diagnosis uses repeated low values and symptoms; in women, androgen-excess thresholds are method-specific and often based on the upper limit for healthy premenopausal women.
A value close to a cutoff deserves more caution than a value that is clearly and repeatedly abnormal. Borderline results may move across the reference limit because of normal biologic variation, recent illness, sleep disruption, exercise, stress, or sample timing. Clinicians often repeat a test under better-controlled conditions before ordering imaging or beginning treatment. The repeat is most useful when the timing, medication list, and assay method are documented.
Trends can be useful when the same question is followed over time, but only when the measurements are reasonably comparable. A change between laboratories may reflect a method difference. A change after starting or stopping hormones may be expected. Record the laboratory, units, collection time, cycle day or pregnancy week, and relevant treatment so later results can be compared in context.
The related bioavailable testosterone test includes free plus albumin-bound testosterone.
What High free testosterone Results Can Mean
High free testosterone can result from excess production, external androgen use, or low SHBG that increases the unbound fraction.
- PCOS or another common ovarian hyperandrogenic pattern.
- Nonclassic CAH or adrenal androgen excess.
- Rare ovarian, testicular, or adrenal androgen-producing tumor.
- Prescribed testosterone dose or sampling near a peak.
- Anabolic steroids, DHEA, prohormones, or contaminated supplements.
- Low SHBG associated with obesity, insulin resistance, hypothyroidism, or androgen exposure.
In women, gradual hirsutism and irregular cycles commonly fit PCOS. Rapid voice deepening, clitoromegaly, sudden severe hair growth, or a markedly elevated value requires prompt confirmation and tumor evaluation. Testosterone should be measured with a method accurate at female concentrations.
In men on treatment, excessive exposure can raise hematocrit, worsen acne, cause edema, suppress sperm, and produce other adverse effects. The dose should be reviewed with symptoms, safety tests, and formulation timing rather than adjusted from one free value.
Confirm an unexpected high result with accurate total testosterone and SHBG. Review supplements and treatment before ordering imaging. Rapid virilization or a mass requires faster specialist care.
Women with irregular cycles and androgen excess may need a PCOS hormone panel.
What Low free testosterone Results Can Mean
Low free testosterone can reflect reduced gonadal production, high SHBG, central suppression, illness, or poor sample timing.
- Primary testicular failure, usually with high LH and FSH.
- Pituitary or hypothalamic hypogonadism, often with low or normal gonadotropins.
- High SHBG from hyperthyroidism, liver disease, estrogen exposure, or some medicines.
- Obesity, sleep apnea, severe illness, undernutrition, or overtraining.
- Opioids, glucocorticoids, chemotherapy, or prior anabolic-steroid use.
- Normal age-related change or a method-specific low result.
Men should not be diagnosed or treated from a single low result. Repeat morning total testosterone and free testosterone when SHBG is abnormal, then evaluate LH, FSH, prolactin, iron status, medicines, sleep, and systemic disease. Fertility goals are essential because external testosterone suppresses intratesticular testosterone and sperm production.
Low free testosterone in women has no broadly accepted syndrome or treatment threshold. Testosterone therapy is not a general treatment for fatigue, weight change, or low mood. Selected postmenopausal sexual-interest disorders require a separate evidence-based assessment and careful dosing.
Address reversible causes and confirm persistent deficiency before treatment. When pituitary disease is possible, assess other pituitary hormones and imaging indications rather than focusing only on testosterone.
A prolactin test may be appropriate when low testosterone occurs with low gonadotropins, headaches, or galactorrhea.
How Results Fit With Other Hormones and Tests
Free testosterone is best interpreted with total testosterone, SHBG, albumin, LH, and FSH.
| Pattern | Possible explanation | Next step |
|---|---|---|
| Low total + low free + high LH | Primary testicular failure | Confirm and assess testicular cause |
| Low total + low free + low/normal LH | Central or functional suppression | Check prolactin, illness, medicines, pituitary |
| Normal total + low free + high SHBG | Increased binding | Review thyroid, liver, estrogen, medicines |
| Low total + normal free + low SHBG | Binding effect, often metabolic | Avoid diagnosis from total alone |
| High free in woman + low SHBG | PCOS/metabolic pattern possible | Assess cycles, androgens, and exclusion tests |
Discordance between symptoms and laboratory results is a reason to verify method and context, not to choose whichever number fits the preferred diagnosis. Repeat testing with a validated method can prevent unnecessary lifelong treatment.
Next Steps After the Result
Follow-up should establish whether the result is real, whether symptoms match it, and whether the cause lies in production, binding, or external hormone exposure.
- Check units, method, total testosterone, SHBG, albumin, collection time, and treatment timing.
- Repeat low morning testing in men on a separate day.
- Use LH and FSH to distinguish primary from central hypogonadism.
- Evaluate prolactin, thyroid, liver, sleep, medicines, and systemic illness as indicated.
- Review fertility goals before testosterone treatment.
- Monitor clinical benefit and safety rather than pursuing an arbitrary “optimal” free level.
When testosterone therapy is appropriate, the formulation, dose, follow-up interval, and safety monitoring should be individualized. Men actively seeking fertility may need gonadotropin-based or other specialist approaches instead. Women with androgen excess are treated according to the cause, symptoms, and pregnancy plans.
Bring the actual report to the follow-up visit rather than only recalling that the level was “high” or “low.” The report shows units, the laboratory interval, specimen type, and sometimes the assay method. Ask whether the result needs confirmation, whether a related hormone should be measured at the same time, and what finding would change management.
A useful plan defines the next step and its timing. That may be no action, a repeat test, a dynamic stimulation or suppression test, ultrasound, semen analysis, genetic testing, or referral to endocrinology, reproductive endocrinology, urology, or maternal-fetal medicine. It should also identify symptoms that warrant earlier contact instead of waiting for the routine appointment.
Rapidly progressive symptoms deserve faster evaluation than a mild, stable laboratory abnormality. Examples include sudden virilization, severe headache with visual change, signs of adrenal crisis, heavy bleeding with dizziness, or concerning pregnancy symptoms. The laboratory number may guide the workup, but urgent decisions are driven by the whole clinical picture.
Treatment should address the confirmed cause and the person’s goals. Lowering or raising a laboratory value without establishing why it is abnormal can hide an important condition or create new problems. Hormone therapy can affect fertility, blood counts, liver function, clot risk, bone health, and pregnancy, so monitoring plans should be individualized.
Seek prompt care for rapid virilization, a new testicular or abdominal mass, or severe headache with visual change. Emergency symptoms such as chest pain, severe shortness of breath, or neurologic deficits require immediate care regardless of testosterone level.
When a repeat measurement is planned, try to reproduce the conditions that matter for this test. Use the same laboratory when practical, note the collection time, and record any change in medicines or reproductive stage. Consistency does not remove all biologic variation, but it makes a true trend easier to distinguish from noise.
Reference intervals describe a population selected by the laboratory; they do not define a treatment target for every person. A result inside the interval can still require attention when symptoms are strong or when another hormone shows a clear mismatch. Conversely, a small deviation may not represent disease when the timing or clinical setting explains it.
A laboratory result can answer only the question built into the test. It may show hormone concentration, but it cannot by itself prove ovulation quality, egg quality, sperm production, placental health, or the cause of a symptom. Those conclusions usually require a combination of history, examination, imaging, and other targeted tests.
When fertility is the concern, age, duration of trying to conceive, menstrual pattern, pregnancy history, semen findings, and tubal or uterine factors often affect the plan as much as a single hormone value. Testing both partners in parallel can prevent months of delay and reduce the chance that an incidental hormone result distracts from a more direct cause.
When symptoms are being monitored rather than fertility, define the outcome that treatment is meant to improve. Examples include restoration of periods, relief of hot flashes, reduction of unwanted hair growth, recovery of sexual function, preservation of bone health, or safe progression of puberty. Laboratory monitoring is most useful when tied to one of these clinical outcomes.
People using nonprescription “hormone balance” products should mention them before testing. DHEA, progesterone creams, testosterone boosters, compounded preparations, and biotin can alter physiology or make results harder to interpret. Product labels may not reliably predict the dose absorbed, so the safest approach is to review the exact container or ingredient list with the clinician.
Results can also differ because laboratories report conventional and SI units. A value expressed in ng/dL cannot be compared directly with one expressed in nmol/L without a hormone-specific conversion. Always compare the number, unit, and interval together. This simple check prevents many apparent contradictions between reports.
An abnormal result can have emotional weight, especially during fertility treatment, pregnancy, or puberty evaluation. Ask the clinician to separate what is known from what remains uncertain. A clear explanation of the likely causes, the confirmation plan, and the time frame for action is more useful than trying to interpret every decimal place independently.
Clinicians also consider whether the test result agrees with the physical findings. A marked biochemical abnormality without expected symptoms may prompt confirmation with a more specific laboratory method. Strong symptoms with a normal result may lead to testing at a different time, measuring a related hormone, or looking for a nonhormonal cause.
The pace of change can be as important as the level itself. Slow changes over years commonly fit physiologic aging or a chronic endocrine condition. Changes over weeks or a few months raise more concern for a new medicine effect, pregnancy-related change, acute illness, or a hormone-producing lesion, especially when symptoms progress quickly.
No single follow-up pathway fits every abnormal value. Mild and explainable results may only need observation. Persistent or substantial abnormalities may require specialist review and tests chosen to locate the source of hormone production or the level of signaling failure. The sequence should be deliberate so that each test answers a specific unresolved question.
Keep a copy of the laboratory report and the order indication. The clinician needs more than the highlighted flag: the numeric value, unit, reference interval, specimen type, collection date and time, and any comment about the assay can change interpretation. A result copied into a patient portal message without those details may be impossible to compare with a later test. This documentation is especially important when care moves between a primary clinician, endocrinologist, fertility clinic, and hospital laboratory.
Before repeating testing, decide what the repeat is meant to resolve. It may confirm persistence, correct a timing error, remove a medication effect, or use a more specific assay. Repeating the same poorly timed test without changing the conditions often reproduces uncertainty rather than solving it. The clinician should also state what result would lead to observation, another laboratory test, imaging, or treatment.
Small deviations from a reference interval are common because the interval usually contains about 95% of a selected comparison population. Some healthy people fall outside it, while some people with disease fall inside it. The clinical importance depends on how far the value is from the limit, whether it persists, whether related hormones agree, and whether symptoms fit the physiology. A reference flag is therefore a prompt for interpretation, not proof of disease.
Hormone results are also affected by changes in binding proteins and metabolism. Liver disease, thyroid disease, kidney disease, pregnancy, body composition, and oral estrogen exposure can change measured concentrations without producing the same change in tissue effect. When a binding issue is suspected, the clinician may use a free or calculated hormone, a related binding protein, or a more specific laboratory method rather than interpreting the total concentration alone.
Fertility decisions should not be reduced to a single endocrine value. A hormone may help choose medication dose, confirm ovulation, or identify a treatable disorder, but it does not measure every step required for pregnancy. Reproductive age, sperm exposure or semen quality, tubal patency, uterine anatomy, timing, prior pregnancies, and the duration of trying all influence the next step. A balanced evaluation prevents overreaction to an incidental result.
Testing can be different during pregnancy, adolescence, menopause, or hormone treatment because physiology is intentionally changing. A range derived from untreated adults may be inappropriate in these settings. Ask whether the laboratory interval matches the patient’s age and reproductive state and whether the clinical team uses a separate treatment or pregnancy target. This is particularly important when a portal automatically marks a result high or low against a generic range.
References
- Use of calculated free testosterone in men: advantages and limitations 2024 (Review)
- Reference intervals for free testosterone in adult men measured using a standardized equilibrium dialysis procedure 2023 (Study)
- A survey on measurement and reporting of total and free testosterone by clinical laboratories in the United Kingdom 2025 (Study)
- Recommendations for the measurement of sexual steroids in clinical practice. A position statement of SEQCML/SEEN/SEEP 2023 (Position Statement)
- Clinical utility of laboratory developed mass spectrometry assays for steroid hormone testing 2023 (Review)
Disclaimer
This article is educational and cannot diagnose testosterone deficiency or androgen excess. Free testosterone depends on timing, sex, age, SHBG, treatment, and laboratory method. Do not start or adjust hormone therapy without clinical supervision.
